Evidence map›Paper›PMID 26315111›Full record

ArticleOncotarget2015

A genome-wide assessment of rare copy number variants in colorectal cancer.

Zhenli Li, Dan Yu, Meifu Gan, Qiaonan Shan, Xiaoyang Yin, Shunli Tang, Shuai Zhang, Yongyong Shi, Yimin Zhu, Maode Lai and 1 more

Abstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Mutation Profiling of Premalignant Colorectal Neoplasia.Gastroenterology research and practice · 2019
    Article
  4. Article
  5. Article
  6. Candidate predisposing germline copy number variants in early onset colorectal cancer patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhenli LiDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.
Dan YuDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.
Meifu GanDepartment of Pathology, Taizhou Hospital, Linhai, Zhejiang, 317000, China.
Qiaonan ShanZhejiang University School of Clinical Medicine, Hangzhou, Zhejiang, 310058, China.
Xiaoyang YinZhejiang University School of Clinical Medicine, Hangzhou, Zhejiang, 310058, China.
Shunli TangZhejiang University School of Clinical Medicine, Hangzhou, Zhejiang, 310058, China.
Shuai ZhangDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.
Yongyong ShiBio-X Institutes, Key Laboratory for The Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, 200000, China.
Yimin ZhuDepartment of Epidemiology & Biostatistics, Zhejiang University School of Public Health, Hangzhou, Zhejiang, 310058, China.
Maode LaiDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.
Dandan ZhangDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is a complex disease with an estimated heritability of approximately 35%. However, known CRC-related common single nucleotide polymorphisms (SNPs) can only explain ~0.65% of the heritability. This "missing heritability" may be explained partially by rare copy number variants (CNVs). In this study, we performed a genome-wide scan using Illumina Human-Omni Express BeadChip, 694 sporadic CRC cases and 1641 controls were eventually included in our analysis after quality control. The global burden analysis revealed a 1.53-fold excess of rare CNVs in CRC cases compared with controls (P < 1 × 10(-6)), and the difference being more pronounced for genic rare CNVs and CNVs overlapped with coding regions (1.65-fold and 1.84-fold, respectively, both P < 1 × 10(-6)). Interestingly, both the cases in the lowest and middle tertile of age carried a higher burden of rare CNVs comparing to the highest tertile. Furthermore, 639 CNV-disrupted genes exclusive to CRC cases were found to be significantly enriched in gene ontology (GO) terms concerning nucleosome assembly and olfactory receptor activity. Our study was the first to evaluate the burden of rare CNVs in sporadic CRC and suggested that rare CNVs contributed to the missing heritability of CRC.

Indexed as

DNA Copy Number VariationsAgedAge FactorsBiomarkers, TumorCase-Control StudiesColorectal NeoplasmsComputational BiologyDatabases, GeneticFemaleGene Expression ProfilingGenetic Predisposition to DiseaseGenome-Wide Association StudyHeredityHumansMaleMiddle AgedBiomarkers, Tumorcolorectal cancergenome-wide scannucleosome assemblyrare CNVs

Identifiers

PMID26315111
PMCPMC4694911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.